NCT02245165View on ClinicalTrials.gov

Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Gastrointestinal Motility DisorderDisturbance of Salivary Secretion
Interventions
BIOLOGICAL

L-Nitro-Monomethyl-Arginine (LNMMA) 10 mg/kg IV

BIOLOGICAL

saline

Trial Locations (1)

75185

Uppsala University, Uppsala

All Listed Sponsors
collaborator

Bengt Ihre Foundation

OTHER

collaborator

The Swedish Society of Medicine

OTHER

lead

Uppsala University

OTHER

NCT02245165 - Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades | Biotech Hunter | Biotech Hunter